HomeCompareCMHHY vs MRK

CMHHY vs MRK: Dividend Comparison 2026

CMHHY yields 5.58% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CMHHY wins by $1.01M in total portfolio value
10 years
CMHHY
CMHHY
● Live price
5.58%
Share price
$19.00
Annual div
$1.06
5Y div CAGR
50.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.06M
Annual income
$665,825.42
Full CMHHY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CMHHY vs MRK

📍 CMHHY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMHHYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CMHHY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CMHHY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMHHY
Annual income on $10K today (after 15% tax)
$474.20/yr
After 10yr DRIP, annual income (after tax)
$565,951.61/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CMHHY beats the other by $557,623.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMHHY + MRK for your $10,000?

CMHHY: 50%MRK: 50%
100% MRK50/50100% CMHHY
Portfolio after 10yr
$560.8K
Annual income
$337,811.78/yr
Blended yield
60.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CMHHY
No analyst data
Altman Z
1.3
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMHHY buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMHHYMRK
Forward yield5.58%2.76%
Annual dividend / share$1.06$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR50.3%32.7%
Portfolio after 10y$1.06M$56.8K
Annual income after 10y$665,825.42$9,798.13
Total dividends collected$1.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CMHHY vs MRK ($10,000, DRIP)

YearCMHHY PortfolioCMHHY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,538$838.50$11,206$366.19+$332.00CMHHY
2$13,705$1,359.03$12,650$502.35+$1.1KCMHHY
3$16,932$2,267.46$14,407$694.19+$2.5KCMHHY
4$22,052$3,934.94$16,585$967.82+$5.5KCMHHY
5$30,795$7,198.74$19,342$1,363.89+$11.5KCMHHY
6$47,071$14,120.63$22,913$1,947.19+$24.2KCMHHY
7$80,684$30,318.42$27,662$2,823.89+$53.0KCMHHY
8$159,331$72,999.22$34,159$4,173.35+$125.2KCMHHY
9$372,976$202,491.10$43,337$6,308.80+$329.6KCMHHY
10$1,064,909$665,825.42$56,776$9,798.13+$1.01MCMHHY

CMHHY vs MRK: Complete Analysis 2026

CMHHYStock

China Merchants Port Holdings Company Limited, an investment holding company, operates as a port operator in Mainland China, Hong Kong, Taiwan, and internationally. It operates through Ports operation, Bonded Logistics Operation, and Other Operations. The company engages in the container, and bulk and general cargo terminals; and logistic park operation, ports transportation, and airport cargo handling activities. It also invests, develops, and constructs modular housings; and provides container terminal services. In addition, the company engages in port construction and development; and operation of berths; operation of tugboats. Further, it offers tugboat berthing assistance and barge services at the arrival of ships to the ports, tallying in the course of cargo handling, and supply of shore power and freshwater for vessels. The company was formerly known as China Merchants Holdings (International) Company Limited and changed its name to China Merchants Port Holdings Company Limited in June 2016. The company was founded in 1872 and is headquartered in Central, Hong Kong. China Merchants Port Holdings Company Limited is considered as a Red Chip company due to its listing on the Hong Kong Stock Exchange.

Full CMHHY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CMHHY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMHHY vs SCHDCMHHY vs JEPICMHHY vs OCMHHY vs KOCMHHY vs MAINCMHHY vs JNJCMHHY vs ABBVCMHHY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.